
Vitex agnus-castus Ze 440
A summary of the research showing the efficacy and tolerability of Ze 440 (specific extract of Vitex agnus-castus) in premenstrual syndrome symptomatology and menstrual cycle irregularities.
This 3 part webinar series from SFI Health provides an in-depth overview of PMS diagnosis and management, including the research and efficacy of the unique Vitex agnus-castus extract Ze 440.
Part 1: PMS and its implications on quality of life (10 min)
Part 2: Diagnosis and Management of PMS/PMD (17 min)
Part 3: Vitex agnus castus extract Ze 440 in the management of PMS (14 min)
Already registered to the SFI Health website? Simply login here to watch.
Doctor Si Chen is the business development manager of the medical division at Max Zeller Söhne AG, with a scientific background in diverse therapeutic areas, and a PhD in molecular neurobiology.
The latest 3 part complimentary miniseries from SFI Health provides an in-depth overview of PMS, discusses the recommended first line therapy Vitex agnus-castus, and reviews the research and efficacy of the unique extract Ze 440.
International expert Dr Chen will provide valuable clinical insights on all aspects of PMS, including:
A summary of the research showing the efficacy and tolerability of Ze 440 (specific extract of Vitex agnus-castus) in premenstrual syndrome symptomatology and menstrual cycle irregularities.
Many practitioners see clients, especially during challenging times, with symptoms associated with anxiety, stress, memory loss, fatigue and poor concentration. Using specific and clinically researched herbal medicines provides assurances of reliable and reproducible clinical results.
We explore the specific research on Vitex agnus-castus Ze 440 that was written and published by Eltbogen R, et al. in 2015.
The menopause transition is a physiologically significant milestone in a women’s life. Most women suffer an array of challenging and unpredictable symptoms that can directly reduce their quality of life every day for many years and often over a decade.